Jensen Investment Management Inc 13F holdings and portfolio analysis
Connectez-vous pour cloner une nouvelle branche à partir du plan sélectionné, puis continuez l'optimisation dans la nouvelle branche.
Baseline
Messages d'analyseQ&R pré-générée sur ce fonds. Utilisez-la comme contexte de référence pour votre propre analyse.
Directly following the baseline exposes an investor to a relatively concentrated large-cap portfolio with a strong information technology skew and meaningful implementation lag. The strategy top 5 account for 30.43% and the top 10 for 47.79%, led by Microsoft at 9.11%, Apple at 7.63%, and NVIDIA at 5.97%. Sector weights are 36.61% Information Technology, 16.8% Industrials, and 13.94% Health Care. The backtest also warns that implementation was active, with 6,951 trades, total estimated cost 1.7017, and a turnover spike to 98.98% in one period, so copycat investors face both concentration and execution risk.
The recent baseline periods that best explain the trade-off are the weak but high-turnover stretches in 2025 and the mixed resilience in late 2024. In 2025-03-31, the baseline returned 2.71% versus 9.22% for SPY, a -6.51 point excess return. In 2025-06-30, it lost -1.69% while SPY gained 4.2%, for another -5.89 point gap, and turnover jumped to 31.23% with 300 trades. By contrast, 2024-12-31 shows the upside of the lower-beta profile: baseline lost -2.62% versus SPY at -3.63%, outperforming by 1.01 points. Those periods show the core trade-off: some downside resilience in certain selloffs, but weak participation in strong benchmark rallies and costly turnover when the manager rotates.
Before accepting the baseline, a user should inspect three things: whether the concentration is tolerable, whether the lagged implementation is realistic, and whether underperformance is concentrated in a few periods or structural. Concentration is material, with top 10 holdings at 47.79% and Information Technology at 36.61%. Implementation realism also matters because the strategy used 6,951 trades with total estimated cost 1.7017 and explicit 13F-style filing delays. Finally, the period data show repeated benchmark shortfalls in 2023-12-31 (-4.44 excess), 2025-03-31 (-6.51 excess), and 2025-06-30 (-5.89 excess), which suggests the negative alpha of -1.05 is not just a one-period anomaly.